Assyro AI
US FDAUnited StatesCRLComplete Response Letter

Complete Response Letter NDA 505b1 214315 (Jan 25, 2024)

Issued January 25, 2024

Issued

January 25, 2024

Application

NDA 505b1 • 214315

Review center

CDER

Stage

Final Decision

Letter type

Complete Response Letter

Response due January 24, 2025Requires resubmission addressing deficiencies.

Document viewer

Read the FDA letter and send context to the co-pilot at any time.

Loading PDF…